The 64th Annual Meeting of the Japan Society of Clinical Oncology (JSCO) [Kobe]
The 64th Annual Meeting of the Japan Society of Clinical Oncology is one of Japan’s major academic meetings in oncology. It brings together the latest developments in basic research, clinical research, and real-world cancer care, while promoting multidisciplinary collaboration to advance oncology practice and patient support.
October 22 (Thu)–24 (Sat), 2026
KOBE Convention Center
Koji Kono, MD, PhD
One team to Conquer Cancer
Event Information
- Date: October 22 (Thu)–24 (Sat), 2026
- Venue:
KOBE Convention Center
(Kobe International Conference Center, Kobe International Exhibition Hall, Kobe Portopia Hotel) - Addresses: Kobe International Conference Center: 6-9-1 Minatojima-nakamachi, Chuo-ku, Kobe 650-0046, Japan / Kobe International Exhibition Hall: 6-11-1 Minatojima-nakamachi, Chuo-ku, Kobe 650-0046, Japan / Kobe Portopia Hotel: 6-10-1 Minatojima Nakamachi, Chuo-ku, Kobe 650-0046, Japan
- Format: On-site meeting
Congress Information
- Name: The 64th Annual Meeting of the Japan Society of Clinical Oncology
- Congress President: Koji Kono, MD, PhD — Director and Vice-President of Fukushima Medical University; Professor and Chairman of Department of Gastrointestinal Tract Surgery, FMU
- Theme: One team to Conquer Cancer
- Congress Secretariat: Department of Gastrointestinal Tract Surgery, Fukushima Medical University
- Management Secretariat: c/o Congrès Inc.
Highlights
- Joint Conference: AOS2026 (6th International Congress of the Asian Oncology Society)
- Special focus on translational research and the next stage of standardization in cancer care
- Featured areas mentioned by the congress president include photoimmunotherapy, the next step in immune checkpoint inhibitor treatment, ctDNA-guided follow-up, and genomic biomarkers
- Planned sessions include 39 organ-specific sessions, 33 interdisciplinary sessions, and JSCO Frontier
Overview
Under the theme “One team to Conquer Cancer,” the meeting is expected to cover a broad range of topics in cancer treatment, including systemic therapy, surgery, radiation oncology, translational research, and multidisciplinary cancer care. The congress president emphasizes the importance of uniting clinicians, researchers, medical staff, and all professionals involved in oncology to improve treatment outcomes and ultimately conquer cancer.
